Your browser doesn't support javascript.
loading
Butyrate Reprograms Expression of Specific Interferon-Stimulated Genes.
Chemudupati, Mahesh; Kenney, Adam D; Smith, Anna C; Fillinger, Robert J; Zhang, Lizhi; Zani, Ashley; Liu, Shan-Lu; Anderson, Matthew Z; Sharma, Amit; Yount, Jacob S.
Afiliação
  • Chemudupati M; Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA.
  • Kenney AD; Infectious Diseases Institute, The Ohio State University, Columbus, Ohio, USA.
  • Smith AC; Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA.
  • Fillinger RJ; Infectious Diseases Institute, The Ohio State University, Columbus, Ohio, USA.
  • Zhang L; Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA.
  • Zani A; Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio, USA.
  • Liu SL; Infectious Diseases Institute, The Ohio State University, Columbus, Ohio, USA.
  • Anderson MZ; Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA.
  • Sharma A; Infectious Diseases Institute, The Ohio State University, Columbus, Ohio, USA.
  • Yount JS; Department of Microbiology, The Ohio State University, Columbus, Ohio, USA.
J Virol ; 94(16)2020 07 30.
Article em En | MEDLINE | ID: mdl-32461320
Butyrate is an abundant metabolite produced by gut microbiota. While butyrate is a known histone deacetylase inhibitor that activates expression of many genes involved in immune system pathways, its effects on virus infections and on the antiviral type I interferon (IFN) response have not been adequately investigated. We found that butyrate increases cellular infection with viruses relevant to human and animal health, including influenza virus, reovirus, HIV-1, human metapneumovirus, and vesicular stomatitis virus. Mechanistically, butyrate suppresses levels of specific antiviral IFN-stimulated gene (ISG) products, such as RIG-I and IFITM3, in human and mouse cells without inhibiting IFN-induced phosphorylation or nuclear translocation of the STAT1 and STAT2 transcription factors. Accordingly, we discovered that although butyrate globally increases baseline expression of more than 800 cellular genes, it strongly represses IFN-induced expression of 60% of ISGs and upregulates 3% of ISGs. Our findings reveal that there are differences in the IFN responsiveness of major subsets of ISGs depending on the presence of butyrate in the cell environment, and overall, they identify a new mechanism by which butyrate influences virus infection of cells.IMPORTANCE Butyrate is a lipid produced by intestinal bacteria. Here, we newly show that butyrate reprograms the innate antiviral immune response mediated by type I interferons (IFNs). Many of the antiviral genes induced by type I IFNs are repressed in the presence of butyrate, resulting in increased virus infection and replication. Our research demonstrates that metabolites produced by the gut microbiome, such as butyrate, can have complex effects on cellular physiology, including dampening of an inflammatory innate immune pathway resulting in a proviral cellular environment. Our work further suggests that butyrate could be broadly used as a tool to increase growth of virus stocks for research and for the generation of vaccines.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Butiratos / Interferon Tipo I / Expressão Gênica Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Virol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Butiratos / Interferon Tipo I / Expressão Gênica Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Virol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos